The Nobel Prize for artemisinin demonstrates that the Chinese scientific community is a significant contributor in the fight against malaria. Artemisinin has been one of the major mainstays of malaria treatments for more than 15 years. Artemisinin compounds are frequently used as part of a combination therapy to decrease the risks of development resistance to the treatments.
All of the nations around the world that have chloroquine-resistant falciparum malaria have chosen to use artemisinin-based therapies as part of their first-line treatments. In addition, they have also opened these therapies to the public sector. As of 2000, over one billion artemisinin-based treatments have been used to help patients who have malaria.
Countless people contract malaria every year through the bite of a mosquito that is infected with the parasite that causes malaria. There are several strains of the disease, and it is known for developing resistance to treatments. This makes it more difficult for scientists to treat the disease, even though it is so common and widespread.
World Health Organization is located at Avenue Appia 20, Geneva, Switzerland.